Skip to content

ARCHITECTRecalls & reported problems across all models

Abbott Laboratories · 51 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

6 open recalls name at least one ARCHITECT model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
5,426
Deaths reported
2
Injuries reported
66
Recalls
11

We found 51 models of ARCHITECT by Abbott Laboratories in the FDA's device registry (GUDID). Together they are named in 5,426 adverse event reports in the FDA's MAUDE database, received between Aug 1, 2016 and Sep 30, 2026 — classified as 2 deaths, 66 injuries, 5,358 malfunctions.

The most frequently reported specific device problem is “High Test Results” (2,020 reports).

11 FDA recall records name at least one of these models by its device identifier, 6 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 30 reportsDec 2023: 31 reportsJan 2024: 26 reportsFeb 2024: 30 reportsMar 2024: 28 reportsApr 2024: 30 reportsMay 2024: 29 reportsJun 2024: 23 reportsJul 2024: 23 reportsAug 2024: 17 reportsSep 2024: 28 reportsOct 2024: 31 reportsNov 2024: 19 reportsDec 2024: 24 reportsJan 2025: 27 reportsFeb 2025: 16 reportsMar 2025: 26 reportsApr 2025: 22 reportsMay 2025: 22 reportsJun 2025: 17 reportsJul 2025: 26 reportsAug 2025: 28 reportsSep 2025: 11 reportsOct 2025: 29 reportsNov 2025: 16 reportsDec 2025: 26 reportsJan 2026: 10 reportsFeb 2026: 16 reportsMar 2026: 17 reportsApr 2026: 17 reportsMay 2026: 4 reportsJun 2026: 3 reportsJul 2026: 1 reportsAug 2026: 3 reportsSep 2026: 11 reportsOct 2026: 0 reports20242025202631
Last 36 months. The most recent month may be incomplete.

ARCHITECT recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Apr 24, 2025Class IIOpen, Classified

    transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

    Z-1844-2025 · Root cause: Storage · Recall details · FDA record ↗

  2. Oct 19, 2023Class IIOpen, Classified

    The devices contain a dry natural rubber (latex) subcomponent, which are not labeled as containing dry natural rubber(latex).

    Z-0682-2024 · Root cause: Under Investigation by firm · names 2 of these models · Recall details · FDA record ↗

  3. Sep 29, 2023Class IIOpen, Classified

    A high recovery of Iron assay has been observed at some customer sites. Internal studies confirmed the positive shift of Quality Control and patient samples results, up to 15% for Iron Products (Alinity c Iron Reagent REF. 08P3920) to be used on Abbott Alinity Instrument and to 30% for Iron Products (IRON REF. 6K95-41 and IRON REF. 6K95- 30) to be used on Abbott Architect Instrument. When using the affected lots, there is a potential for delay in reporting patient results due to QC failure, also a potential for falsely elevated results.

    Z-0325-2024 · Root cause: Under Investigation by firm · names 2 of these models · Recall details · FDA record ↗

  4. Jul 26, 2022Class IIOpen, Classified

    One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component.

    Z-1660-2022 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  5. Sep 29, 2021Class IIOpen, Classified

    Twelve software-related issues affecting software version 9.41 and earlier were identified. The issues include bypassing error codes, incorrect calibration, loss of module communication leading to overfilling wash buffer containers, missing QC flags, signal spikes, abnormal optics reads, and incorrect sample aspiration. The issues may lead to inaccurate results with an unknown bias direction and magnitude for assays measuring cardiac, metabolic (including diabetes), toxicology, prenatal, therapeutic drug monitoring, infectious disease, oncology, hepatic, pancreatic, hematological, endocrinologic, inflammatory analytes.

    Z-0272-2022 · Root cause: Software design · names 2 of these models · Recall details · FDA record ↗

  6. Sep 29, 2021Class IIOpen, Classified

    Twelve software-related issues affecting software version 9.41 and earlier were identified. The issues include bypassing error codes, incorrect calibration, loss of module communication leading to overfilling wash buffer containers, missing QC flags, signal spikes, abnormal optics reads, and incorrect sample aspiration. The issues may lead to inaccurate results with an unknown bias direction and magnitude for assays measuring cardiac, metabolic (including diabetes), toxicology, prenatal, therapeutic drug monitoring, infectious disease, oncology, hepatic, pancreatic, hematological, endocrinologic, inflammatory analytes.

    Z-0271-2022 · Root cause: Software design · names 3 of these models · Recall details · FDA record ↗

  7. May 24, 2019Class IIITerminated

    Presence of a time dependent, stability drift in patient and control results returned from ARCHITECT BNP testing.

    Z-2079-2019 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  8. May 24, 2019Class IIITerminated

    Presence of a time dependent, stability drift in patient and control results returned from ARCHITECT BNP testing.

    Z-2078-2019 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  9. Jan 2, 2019Class IITerminated

    Abbott internal testing has identified that the Magnesium urine application demonstrates depressed urine result recovery. All samples >0.5mEq/L fail the linearity acceptance criteria for the bias specification and demonstrate depressed recovery of up to 37%. The specific cause of the negative bias/depressed results is currently under investigation.

    Z-0971-2019 · Root cause: Under Investigation by firm · names 2 of these models · Recall details · FDA record ↗

  10. Aug 28, 2018Class IITerminated

    There is a potential to generate falsely elevated serum or plasma chloride results when using the product.

    Z-1296-2019 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  11. Jul 18, 2018Class IITerminated

    The product has a stability issue which may lead to an error code indicating "Unable to calculate result, reaction check failure" and/or Quality Control results out of range low.

    Z-1075-2019 · Root cause: Material/Component Contamination · Recall details · FDA record ↗

Most reported ARCHITECT problems

Device problems

  • High Test Results2,020
  • Unable to Obtain Readings1,372
  • Low Test Results1,036
  • False Positive Result409
  • Smoking96
  • Incorrect, Inadequate or Imprecise Result or Readings86
  • False Negative Result75
  • Leak/Splash66

Patient problems

  • No Known Impact Or Consequence To Patient2,020
  • No Clinical Signs, Symptoms or Conditions1,843
  • No Patient Involvement1,197
  • No Consequences Or Impact To Patient256
  • No Code Available41
  • Injury13
  • Premature Labor9
  • Exposure to Body Fluids6

ARCHITECT models

51 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent ARCHITECT adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Abbott Laboratories products

All Abbott Laboratories devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page